Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
That commitment is why so many labs Shop All Peptides with us
FOXO4-DRI vs MOTS-c FOXO4-DRI and MOTS-c represent two fundamentally different approaches to biological aging, targeting distinct hallmarks of the aging process
Since internal production drops significantly after the mid-twenties, older adults may require a higher daily dose to maintain the same cellular protection they had in their youth
Amsterdam, etc.: Elsevier
While not yet FDA-approved as a standalone agent, cagrilintide peptide therapy is being investigated for: Obesity treatment Metabolic syndrome management Adjunctive therapy for GLP-1 agonist non-responders Research in combination with emerging agents like retatrutide Note: As of 2025, cagrilintide is still considered a research compound in many jurisdictions
The treatment is ideal for individuals seeking: Skin brightening and anti-aging solutions
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
